Rapid Fat Loss Diets

Sunday, November 1, 2009

Agarikon (Fomitopsis officinalis) - Tree Fungus with Medicinal Aspirations

By Dr. Markho Rafael

Interviewed on NPR, world leading medicinal mushroom specialist Paul Stamets relates how he came to discover the healing properties of agarikon, an increasingly rare wood conk that has all but vanished from Europe and now grows almost exclusively in the old growth rainforests of the northwestern United States.

Stamets knew that fungi (mushrooms) were more closely related to humans than to plants and therefore susceptible to many of the same pathogens (bacteria, molds, viruses). And yet the perennial agarikon mushroom managed to remain disease free in the dripping wet rainforests for up to 50 years without decaying from rot, mold, or bacteria. So therefore it followed, he figured, that it must possess a powerful immune system full of antibiotic compounds that might benefit people.

Agarikon in the wild looks somewhat like a beehive on the trunk of some of the giant, ancient trees of the old-growth forests of the American northwest. (See picture of Paul Stamets with one of these wood conks by clicking on the agarikon-link on this page.) Be aware that this is an endangered species, which should be left unharmed in the wild. But be sure to bring your digital camera so you can prove to your mushroom club friends that you saw it.

Paul Stamets now grows his own agarikon, which he uses for his agarikon extract. A sample of this extract was sent to the BIO Shield Program for testing at a top security lab located in Ft. Dietrich, MD. The BIO Shield Program is a division within the Defense Department created to search for remedies against biological warfare agents and bioterrorism threats - e.g. pathogens like smallpox or anthrax.

Within this BIO Shield Program, tens of thousands of natural and manmade compounds have been tested for use against biological warfare pathogens. Drug discovery supervisor John Seacrest was happy to report on the radio show that the agarikon extract provided by Stamets had indeed been one of the few substances tested that had proved effective against smallpox related viruses.

Paul Stamets has since applied for a patent on a mushroom-based anti-viral drug. Boston investor John Norris is one of his financial backers. Mr. Norris believes in the project due in part to the fact that some individuals simply are not willing or not able to be vaccinated against smallpox or other potential biological warfare agents.

A former second in command at the FDA, Mr. Norris is hopeful that he and Paul Stamets will be able to sell hundreds of millions of doses of this agarikon extract to the American, German and British armies' defense stock-piles.

That may still be a few years into the future, though. Paul Stamets new mushroom related anti-viral medicine first has to stand up to exhaustive testing, and then eventually be approved for release by the FDA.

Note: The above article is intended for informational purposes only. Agarikon has not been approved by the FDA for use as a medicinal. Never use any herbal or mushroom-product for medicinal purposes unless advice to do so by a licensed medical practitioner.

Reference: Tom Banse, NPR Morning Edition, Smallpox Defense May Be Found in Mushrooms, August 4, 2005. - 17273

About the Author:

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home